These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22511696)

  • 41. Single and Multiple Dose PK-PD Characterization for Carisoprodol. Part I: Pharmacokinetics, Metabolites, and 2C19 Phenotype Influence. Double-Blind, Placebo-Controlled Clinical Trial in Healthy Volunteers.
    Calvo A; Alonso S; Prieto E; Ascaso-Del-Rio A; Ortuño J; Fernandez N; Portolés A
    J Clin Med; 2022 Feb; 11(3):. PubMed ID: 35160309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantification of urinary 8-iso-PGF2alpha using liquid chromatography-tandem mass spectrometry and association with elevated troponin levels.
    Saenger AK; Laha TJ; Edenfield MJ; Sadrzadeh SM
    Clin Biochem; 2007 Nov; 40(16-17):1297-304. PubMed ID: 17854792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992-2003.
    Høiseth G; Bramness JG; Christophersen AS; Mørland J
    Int J Legal Med; 2007 Sep; 121(5):403-9. PubMed ID: 17115170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monitoring metformin in cardiac patients exposed to contrast media using ultra-high-performance liquid chromatography tandem mass-spectrometry.
    Radwan MA; Al Taweel ES; Al-Moghairi AM; Aloudah NM; Al Babtain MA; Al-Amri HS
    Ther Drug Monit; 2011 Dec; 33(6):742-9. PubMed ID: 22105592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carisoprodol: update on abuse potential and legal status.
    Reeves RR; Burke RS; Kose S
    South Med J; 2012 Nov; 105(11):619-23. PubMed ID: 23128807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carisoprodol (soma): abuse potential and physician unawareness.
    Reeves RR; Carter OS; Pinkofsky HB; Struve FA; Bennett DM
    J Addict Dis; 1999; 18(2):51-6. PubMed ID: 10334375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of scheduling and withdrawal of carisoprodol on prevalence of intoxications with the drug.
    Høiseth G; Karinen R; Sørlid HK; Bramness JG
    Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):345-9. PubMed ID: 19663822
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stimulant and relaxant drugs combined with stimulant and relaxant information: a study of active placebo.
    Flaten MA; Simonsen T; Zahlsen K; Aamo T; Sager G; Olsen H
    Psychopharmacology (Berl); 2004 Nov; 176(3-4):426-34. PubMed ID: 15549277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of some microsomal drug-metabolizing enzymes by inhibitors of cholesterol biosynthesis.
    KATO R; VASSANELLI P; CHIESARA E
    Biochem Pharmacol; 1963 Apr; 12():349-51. PubMed ID: 13958397
    [No Abstract]   [Full Text] [Related]  

  • 50. Impact of Expanding ELISA Screening in DUID Investigations to Include Carisoprodol/Meprobamate and Zolpidem.
    Lu A; Scott KS; Chan-Hosokawa A; Logan BK
    J Anal Toxicol; 2017 Mar; 41(2):134-139. PubMed ID: 27798072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carisoprodol withdrawal after internet purchase.
    Eleid MF; Krahn LE; Agrwal N; Goodman BP
    Neurologist; 2010 Jul; 16(4):262-4. PubMed ID: 20592570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantification of acetylcholine, choline, betaine, and dimethylglycine in human plasma and urine using stable-isotope dilution ultra performance liquid chromatography-tandem mass spectrometry.
    Kirsch SH; Herrmann W; Rabagny Y; Obeid R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3338-44. PubMed ID: 21074502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meprobamate dependence secondary to carisoprodol (Soma) use.
    Littrell RA; Sage T; Miller W
    Am J Drug Alcohol Abuse; 1993; 19(1):133-4. PubMed ID: 8438828
    [No Abstract]   [Full Text] [Related]  

  • 54. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A rapid and sensitive gas chromatographic analysis of meprobamate or carisoprodol in urine and plasma.
    Kintz P; Mangin P; Lugnier AA; Chaumont AJ
    J Anal Toxicol; 1988; 12(2):73-4. PubMed ID: 3379924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of creatinine and specific gravity normalization techniques on xenobiotic biomarkers in smokers' spot and 24-h urines.
    Heavner DL; Morgan WT; Sears SB; Richardson JD; Byrd GD; Ogden MW
    J Pharm Biomed Anal; 2006 Mar; 40(4):928-42. PubMed ID: 16182503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Somatic dysfunction during carisoprodol cessation: evidence for a carisoprodol withdrawal syndrome.
    Reeves RR; Parker JD
    J Am Osteopath Assoc; 2003 Feb; 103(2):75-80. PubMed ID: 12622352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carisoprodol - Effects on Human Performance and Behavior.
    Robertson MM; Marinetti LJ
    Forensic Sci Rev; 2003 Jan; 15(1):1-9. PubMed ID: 26256591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carisoprodol use and abuse in Norway: a pharmacoepidemiological study.
    Bramness JG; Furu K; Engeland A; Skurtveit S
    Br J Clin Pharmacol; 2007 Aug; 64(2):210-8. PubMed ID: 17298482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
    Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
    Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.